Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients

Published:2007-04-23 Issue:7 Volume:21 Page:825-834
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Napravnik Sonia,Keys Jessica R,Quinlivan E Byrd,Wohl David A,Mikeal Oksana V,Eron Joseph J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference28 articles.

1. The prevalence of antiretroviral drug resistance in the United States;Richman;AIDS,2004

2. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing;Lucas;AIDS,2004

3. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy;Harrigan;J Infect Dis,2005

4. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice;Phillips;AIDS,2005

5. Antiretroviral-drug resistance among patients recently infected with HIV;Little;N Engl J Med,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study;International Journal of Infectious Diseases;2024-06

2. Analysis of antiretroviral therapy switch rate and switching pattern for people living with HIV from a national database in Japan;Scientific Reports;2022-02-02

3. Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya;Medicine;2021-10-08

4. Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options;AIDS;2020-10-13

5. Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report;The Lancet Microbe;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3